Phase 1 Metastatic Prostate Cancer trials recruiting now

All Metastatic Prostate Cancer trials, every phase

Other phases for Metastatic Prostate Cancer

Phase 1 Metastatic Prostate Cancer trials

• 177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer
  NCT07145177 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · 1 location
• A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
  NCT05800665 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · 26 locations
• A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer
  NCT07567846 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · 5 locations
• A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab
  NCT06782555 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• ACTinium in Castrate-RESistant Prostate Cancer After LUTEtium
  NCT07414940 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer
  NCT07529717 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 100 Years · Sex: Male · 8 locations
• Phase 1 Trial to Study JANX013 and JANX007 Combination in mCRPC
  NCT07813637 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · 1 location
• Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
  NCT07590934 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 99 Years · Sex: Male · 37 locations
• Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT
  NCT06062745 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · 2 locations
• Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
  NCT07181161 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 130 Years · Sex: Male · 52 locations
• Study of AZD0754 in Participants With Metastatic Prostate Cancer
  NCT06267729 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 130 Years · Sex: Male · 15 locations
• Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
  NCT06800313 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · 18 locations
• Study of ORIC-944 in Patients With Metastatic Prostate Cancer
  NCT05413421 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · 27 locations

Common questions

What does Phase 1 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.